NDC Labeler Swedish Orphan Biovitrum Ab (publ)
Swedish Orphan Biovitrum Ab (publ) labeler's code is 66658. The labeler has 16 products that have an assigned National Drug Code.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Product Type | Status |
---|---|---|---|---|---|---|
66658-102 | Orfadin | Nitisinone | Capsule | Oral | Human Prescription Drug | ACTIVE |
66658-105 | Orfadin | Nitisinone | Capsule | Oral | Human Prescription Drug | ACTIVE |
66658-110 | Orfadin | Nitisinone | Capsule | Oral | Human Prescription Drug | ACTIVE |
66658-113 | Kepivance | Palifermin | Injection, Powder, Lyophilized, For Solution | Intravenous | Human Prescription Drug | ACTIVE |
66658-120 | Orfadin | Nitisinone | Capsule | Oral | Human Prescription Drug | ACTIVE |
66658-204 | Orfadin | Nitisinone | Suspension | Oral | Human Prescription Drug | ACTIVE |
66658-230 | Synagis | Palivizumab | Injection, Solution | Intramuscular | Human Prescription Drug | ACTIVE |
66658-231 | Synagis | Palivizumab | Injection, Solution | Intramuscular | Human Prescription Drug | ACTIVE |
66658-234 | Kineret | Anakinra | Injection, Solution | Subcutaneous | Human Prescription Drug | ACTIVE |
66658-501 | Gamifant | Emapalumab-lzsg | Injection | Intravenous | Human Prescription Drug | ACTIVE |
66658-505 | Gamifant | Emapalumab-lzsg | Injection | Intravenous | Human Prescription Drug | ACTIVE |
66658-510 | Gamifant | Emapalumab-lzsg | Injection | Intravenous | Human Prescription Drug | ACTIVE |
66658-522 | Gamifant | Emapalumab-lzsg | Injection | Intravenous | Human Prescription Drug | ACTIVE |
66658-523 | Gamifant | Emapalumab-lzsg | Injection | Intravenous | Human Prescription Drug | ACTIVE |
66658-524 | Gamifant | Emapalumab-lzsg | Injection | Intravenous | Human Prescription Drug | ACTIVE |
66658-525 | Gamifant | Emapalumab-lzsg | Injection | Intravenous | Human Prescription Drug | ACTIVE |